Thymosin alpha 1: Biological activities, applications and genetic engineering production

Peptides

Volumn 31, Issue 11, 2010, Pages 2151-2158

  Li, Juan ^a   Liu, Chun Hui ^a   Wang, Feng Shan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Applications; Biological activities; Genetic engineering production; Thymosin alpha 1

Indexed keywords

ALPHA INTERFERON; CARMUSTINE; CATALASE; DACARBAZINE; FLUOROURACIL; GLUTATHIONE PEROXIDASE; INTERFERON; INTERFERON OMEGA1; INTERLEUKIN 2; PEGINTERFERON ALPHA2A; RIBAVIRIN; SUPEROXIDE DISMUTASE; THYMOSIN ALPHA1; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACETYLATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY RESPONSE; BIOLOGICAL ACTIVITY; BIOTECHNOLOGICAL PRODUCTION; BREAST ADENOMA; BREAST CANCER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CHEMOEMBOLIZATION; CLINICAL TRIAL; COLORECTAL CANCER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG PURIFICATION; ENZYME ACTIVITY; EUKARYOTE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ENGINEERING; GLIOBLASTOMA; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG METASTASIS; LYMPHOCYTE PROLIFERATION; MELANOMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROKARYOTE; PROTEIN PROCESSING; REVIEW; STEM CELL; T LYMPHOCYTE;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CATTLE; GENETIC ENGINEERING; IMMUNOLOGIC FACTORS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; THYMOSIN;

EUKARYOTA; PROKARYOTA;

EID: 77957841362     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.07.026     Document Type: Review

References (90)

1. A. Ahmed, D.M. Wong, G.B. Thurman, T.L. Low, A.L. Goldstein, and S.J. Sharkis T-lymphocyte maturation: cell surface markers and immune functions induced by T-lymphocyte cell-free products and thymosin polypeptides Ann NY Acad Sci 332 1979 81 94
2. T.T. An, X.Y. Liu, J. Fang, and M.N. Wu Primary assessment of treatment effect of thymosin alpha1 on chemotherapy-induced neurotoxicity Ai Zheng 23 2004 1428 1430
3. P. Andreone, C. Cursaro, A. Gramenzi, A. Buzzi, M.G. Covarelli, and L. Di Giammarino A double-blind, placebocontrolled pilot trial of thymosin alpha 1 for the treatment of chronic hepatitis C Liver 16 3 1996 207 210
4. P. Andreone, A. Gramenzi, C. Cursaro, F. Felline, E. Loggi, and A. D'Errico Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial J Viral Hepatitis 11 1 2004 69 73
5. F. Armutcu, O. Coskun, A. Gürel, M. Kanter, M. Can, and F. Ucar Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats Clin Biochem 38 6 2005 540 547
6. J. Beuth, J.M. Schierholz, and G. Mayer Thymosin alpha(1) applications augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice Cancer Lett 159 1 2000 9 13
7. R. Camerini, A. Ciancio, A. De Rosa, and M. Rizzetto Studies of therapy with thymosin alpha 1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis C Ann NY Acad Sci 1112 2007 368 374
8. R. Camerini, A. Mackiewicz, A. Testori, U. Trefzer, J. Jassem, and V. Ferraresi A large first-line randomized dose-finding, phase II study on thymosin α (IFNα) compared to DTIC plus IFNα in stage IV melanoma tumor response and survival results (ASCO meeting Abstracts) J Clin Oncol 25 2007 8535
9. D. Chadwick, J. Pido-Lopez, A. Pires, N. Imami, F. Gotch, and J.S. Villacian A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstruction in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy Clin Exp Immunol 134 3 2003 477 481
10. C. Chen, M. Li, H. Yang, H. Chai, W. Fisher, and Q. Yao Roles of thymosins in cancers and other organ systems World J Surg 29 3 2005 264 270 (Pubitemid 40768035)
11. F. Chen, X.M. Chen, Z. Chen, H.L. Jiang, X.P. Pan, and Z.R. Hu Construction and applications of a yeast expression system for thymosin alpha 1 Biocell 29 3 2005 253 259
12. P.F. Chen, G.F. Fu, H.Y. Zhang, G.X. Xu, and Y.Y. Hou Liposomal plasmid DNA encoding human thymosin alpha and interferon omega potently inhibits liver tumor growth in ICR mice J Gastroenterol Hepatol 21 10 2006 1538 1543
13. P.F. Chen, H.Y. Zhang, G.F. Fu, G.X. Xu, and Y.Y. Hou Overexpression of soluble human thymosin alpha 1 in Escherichia coli Acta Biochim Biophys Sin 37 2 2005 147 151
14. Y. Chen, A. Wang, L. Zhao, G. Shen, L. Cui, and K. Tang Expression of thymosin alpha1 concatemer in transgenic tomato (Solanum lycopersicum) fruits Biotechnol Appl Biochem 52 Pt 4 2009 303 312
15. Y. Chen, L. Zhao, G. Shen, L. Cui, W. Ren, and H. Zhang Expression and analysis of thymosin alpha1 concatemer in Escherichia coli Biotechnol Appl Biochem 49 Pt 1 2008 51 56
16. R. Daly, and M.T. Hearn Expression of heterologous proteins in pichia pastoris: a useful experimental tool in protein engineering and production J Mol Recognit 18 2 2005 119 138
17. A.L. Demain, and P. Vaishnav Production of recombinant proteins by microbes and higher organisms Biotechnol Adv 27 3 2009 297 306
18. R.S. Esipov, V.N. Stepanenko, K.A. Beyrakhova, T.I. Muravjeva, and A.I. Miroshnikov Production of thymosin alpha1 via non-enzymatic acetylation of the recombinant precursor Biotechnol Appl Biochem 56 1 2010 17 25
19. Y.Z. Fan, H. Chang, Y. Yu, J. Liu, L. Zhao, and D.J. Yang Thymopentin (TP5), an immunomodulatory peptide, suppresses proliferation and induces differentiation in HL-60 cells Biochim Biophys Acta 1763 10 2006 1059 1066
20. α-acetylation of thymosin α1 in Escherichia coli Appl Microbiol Biotechnol 84 2009 99 104
21. M.W. Fried, M.X. Shiftman, K.R. Reddy, C. Smith, G. Marinos, and F.L. Goncales Jr. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C vious infection N Engl J Med 347 2002 975 982
22. D. Gao, X. Zhang, J. Zhang, and F. Wang Expression of thymosin alpha1-thymopentin fusion peptide in pichia pastoris and its characterization Arch Pharm Res 31 11 2008 1471 1476
23. Z.C. Gao, J.H. Zhu, Y. Sun, X.L. Ding, J.S. Ma, and Y.X. Cui Clinical investigation of outbreak of nosocomial severe acute respiratory syndrome Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 15 6 2003 332 335
24. E. Garaci Thymosin alpha1: a historical overview Ann NY Acad Sci 1112 2007 14 20
25. E. Garaci, C. Favalli, F. Pica, P. Sinibaldi Vallebona, A.T. Palamar, and C. Matteucci Thymosin alpha 1: from bench to bedside Ann NY Acad Sci 1112 2007 225 234
26. E. Garaci, F. Pica, P. Sinibaldi-Vallebona, P. Pierimarchi, A. Mastino, and C. Matteucci Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer Int Immunopharmacol 3 8 2003 1145 1150
27. E. Garaci, G. Rocchi, L. Perroni, C. D'Agostini, F. Soscia, and S. Grelli Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection Int J Clin Lab Res 24 1 1994 23 28
28. Y. García-Ramos, M. Giraud, J. Tulla-Puche, and F. Albericio Optimized Fmoc solid-phase synthesis of Thymosin alpha1 by side-chain anchoring onto a PEG resin Biopolymers 92 6 2009 565 572
29. R.G. Gish, S.C. Gordon, D. Nelson, V. Rustgi, and I. Rios A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma Hepatol Int 3 2009 480 489
30. C. Giuliani, G. Napolitano, A. Mastino, S. Di Vincenzo, C. D'Agostini, and S. Grelli Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level Eur J Immunol 30 3 2000 778 786
31. A.L. Goldstein History of the discovery of the thymosins Ann NY Acad Sci 1112 2007 1 13
32. A.L. Goldstein, and M. Badamchian Thymosins: chemistry and biological properties in health and diseases Expert Opin Biol Ther 4 4 2004 559 573
33. A.L. Goldstein, and A.L. Goldstein From lab to bedside: emerging clinical applicationss of thymosin alpha 1 Expert Opin Biol Ther 9 5 2009 593 608
34. A.L. Goldstein, T.L. Low, M. McAdoo, J. McClure, G.B. Thurman, and J. Rossio Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide Proc Natl Acad Sci USA 74 2 1977 725 729
35. A.L. Goldstein, F.D. Slater, and A. White Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin) Proc Natl Acad Sci USA 56 3 1966 1010 1017
36. J.A. Hooper, M.C. McDaniel, G.B. Thurman, G.H. Cohen, R.S. Schulof, and A.L. Goldstein Purification and properties of bovine thymosin Ann NY Acad Sci 249 1975 125 144
37. S. Iino, J. Toyota, H. Kumada, K. Kiyosawa, S. Kakumu, and M. Sata The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial J Viral Hepatitis 12 3 2005 300 306
38. S.M. Ji, L.S. Li, Q.Q. Sun, J.S. Chen, G.Z. Sha, and Z.H. Liu Immunoregulation of thymosin alpha 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation Transplant Proc 39 1 2007 115 119
39. S. Kapoor The rapidly expanding therapeutic role of thymosin alpha-1 in the management of gastrointestinal and systemic infectious disorders J Intensive Care Med 24 3 2009 210 211
40. S. Këllii, and G. Burazeri Thymosin alphal: a promising molecule for important clinical applications Med Arh 63 1 2009 48 50
41. H.W. Lee, J.I. Lee, S.H. Um, S.H. Ahn, H.Y. Chang, and Y.K. Park Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: a prospective randomized, comparative pilot study J Gastroenterol Hepatol 23 5 2008 729 735
42. K.D. Leichtling, S.A. Serrate, and M.B. Sztein Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes Int J Immunopharmacol 12 1 1990 19 29
43. L. Yumin, C. Hao, L. Xun, Z. Wence, H. Minyan, and M. Chiriva-Internati A new immunomodulatory therapy for severe sepsis: ulinastatin plus thymosin {alpha} 1 J Intensive Care Med 24 1 2009 47 53
44. Y.F. Liaw Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B J Gastroenterol Hepatol 19 12 2004 S73 S75
45. X. Liu, F. Liu, B. Li, H. Zhou, and Q. Wang Expression and activity analysis of interferonalpha-con and thymosin-alpha1 Sheng Wu Gong Cheng Xue Bao 24 7 2008 1168 1173
46. M. Lopez, S. Carpano, R. Cavaliere, L. Di Lauro, F. Ameglio, and G. Vitelli Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with meta-static melanoma: clinical and immunological effects Ann Oncol 5 8 1994 741 746
47. T.L. Low, G.B. Thurman, M. McAdoo, J. McClure, J.L. Rossio, and P.H. Naylor The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus J Biol Chem 254 3 1979 981 986
48. H.E. Lynch, G.L. Goldberg, A. Chidgey, M.R. Van den Brink, R. Boyd, and G.D. Sempowski Thymic involution and immune reconstitution Trends Immunol 30 7 2009 366 373
49. L.N. Ma, X.Y. Chen, J. Chen, Y.L. Huang, and C.L. Shen A clinical study of thymosin alpha1 as an auxiliary in treating spontaneous peritonitis in patients with liver cirrhosis Zhonghua Gan Zang Bing Za Zhi 15 3 2007 225 230
50. K.M. Malinda, G.S. Sidhu, K.K. Banaudha, J.P. Gaddipati, R.K. Maheshwari, and A.L. Goldstein Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing J Immunol 160 2 1998 1001 1006
51. A.J. McMichael, and S.L. Rowland-Jones Cellular immune responses to HIV Nature 410 6831 2001 980 987
52. T.W. Moody, C. Tuthill, M. Badamchian, and A.L. Goldstein Thymosin alpha1 inhibits mammary carcinogenesis in Fisher rats Peptides 23 5 2002 1011 1014
53. T.W. Moody Thymosin alpha 1 as a chemopreventive agent in lung and breast cancer Ann NY Acad Sci 1112 2007 297 304
54. P.H. Naylor, K. Quadrini, E. Garaci, G. Rasi, and J.W. Hadden Immunopharmacology of thymosin alpha 1 and cytokine synergy Ann NY Acad Sci 1112 2007 235 244
55. Y. Ni, Z. Shi, D. Wang, M. Yao, M. Qiao, and P. Guo High expression of thymosin alpha 1 by injecting recombinant PVX vector into the tomato fruit Sheng Wu Gong Cheng Xue Bao 25 4 2009 537 541
56. X. Peng, P. Zhang, X. Wang, J. Chan, M. Zhu, and M. Jiang Signaling pathways leading to the activation of IKK and MAPK by thymosin alpha 1 Ann NY Acad Sci 1112 2007 339 350
57. Y. Peng, Z. Chen, W. Yu, Q. Zhou, L. Xu, and F.F. Mao Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells Cell Biol Int 32 10 2008 1265 1271
58. T. Piratvisuth Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B Hepatol Int 2 2 2008 140 146
59. J.L. Poo, F. Sánchez Avila, D. Kershenobich, X. García Samper, R. Torress-Ibarra, and J. Góngora Efficacy of triple therapy with thymalfasin, peginterferon alpha-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders Ann Hepatol 7 4 2008 369 375
60. Y. Qin, F.D. Chen, L. Zhou, X.G. Gong, and Q.F. Han Proliferative and anti-proliferative effects of thymosin alpha 1 on cells are associated with manipulation of cellular ROS levels Chem Biol Interact 180 3 2009 383 388
61. L. Qiu, C. Zhang, J. Zhang, J. Liang, J. Liu, and C. Ji Intraperitoneal co-administration of thymosin alpha-1 ameliorates streptozotocin-induced pancreatic lesions and diabetes in C57BL/6 mice Int J Mol Med 23 5 2009 597 602
62. L. Romani, F. Bistoni, R. Graziano, S. Bozza, C. Montagnoli, and K. Perruccio Thymosin alpha 1 activates dendritic cells for fungal Th1 resistance through Toll-like receptor signaling Blood 103 11 2004 4232 4239
63. L. Romani, F. Bistoni, C. Montagnoli, R. Gaziano, S. Bozza, and P. Bonifazi Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance Ann NY Acad Sci 1112 2007 326 338
64. L. Romani, F. Bistoni, K. Perruccio, C. Montagnoli, R. Gaziano, and S. Bozza Thymosin alpha 1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance Blood 108 7 2006 2265 2274
65. B. Roy-Chaudhuri, N. Kirthi, T. Kelley, and G.M. Culver Suppression of a cold-sensitive mutation in ribosomal protein S5 reveals a role for RimJ in ribosome biogenesis Mol Microbiol 68 6 2008 1547 1559
66. V. Rustgi Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment J Gastroenterol Hepatol 19 12 2004 S76 S78
67. V.K. Rustgi Thymalfasin for the treatment of chronic hepatisis C infection Expert Rev Anti Infect Ther 3 6 2005 885 892
68. R.S. Schulof, M.J. Lloyd, P.A. Cleary, S.R. Palaszynski, D.A. Mai, and J.W. Cox Jr. A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer J Biol Response Mod 4 2 1985 147 158
69. Q. Shen, R. Tian, W. Ma, Q. Yuan, and Y. Gong Construction and expression of a new fusion protein, thymosin alpha 1-cBLyS, in E. coli Biotechnol Lett 27 3 2005 143 148
70. I.Z. Siemion, A. Kluczyk, and M. Cebrat The peptide molecular links between the central nervous and the immune systems Amino Acids 29 3 2005 161 176
71. A. Sodhi, and S. Paul Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1 Int Immunopharmacol 2 1 2002 47 58
72. B.L. Spangelo, D.D. Farrimond, M. Thapa, C.M. Bulathsinghala, K.L. Bowman, and A. Sareh Thymosin fraction 5 inhibits the proliferation of the rat neuroendocrine MMQ pituitary adenoma and C6 glioma cell lines in vitro Endocrinology 139 4 1998 2155 2162
73. A. Sungarian, D. Cielo, P. Sampath, N. Bowling, P. Moskal, and J.R. Wands Potential role of thymosin-alpha1 adjuvant therapy for glioblastoma J Oncol 2009 2009 302084
74. N. Takizawa, M. Morita, K. Adachi, K. Watanabe, and N. Kobayashi Induction of immune responses to a human immunodeficiencyvirus type 1 epitope by novel chimeric influenza viruses Drug Discov Ther 3 6 2009 252 259
75. K. Terpe Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems Appl Microbiol Biotechnol 72 2 2006 211 222
76. J.P. Tischio, J.E. Patrick, H.S. Weintraub, ChasinM, and G. Goldstein Short in vitro half-life of thymopoietin 32-36 pentapeptide in human plasma Int J Pept Protein Res 14 1979 479 484
77. M. Uicickas Yood, C.P. Quesenberry Jr., D. Guo, K. Wells, J. Shan, and L. Sanders Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm J Viral Hepatol 15 1 2008 28 36
78. S.S. Wang, R. Makofske, A. Bach, and R.B. Merrifield Automated synthesis of thymosin alpha 1 Int J Pept Protein Res 15 1980 1 4
79. T.W. Wong, and R.B. Merrifield Solid-phase synthesis of thymosin alpha 1 using tert-butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin Biochemistry 19 14 1980 3233 3238
80. R. Wetzel, H.L. Heyneker, D.V. Goeddel, P. Juhrani, J. Shapiro, and R. Crea Production of biologically active Nα-desacetyl thymosin α1 in Escherichia coli through expression of a chemically synthesized gene Biochemistry 19 1980 6096 6104
81. S. Yang, Z.W. Liu, W.X. Zhou, and Y.X. Zhang Thymosin alpha-1 modulate excitatory synaptic transmission in cultured hippocampal neurons in rats Neurosci Lett 350 2003 81 84 (Pubitemid 37101419)
82. Y.F. Yang, H.Y. Yuan, N.S. Liu, X.L. Chen, B.Y. Gao, and H. Lu Construction, expression and characterization of human interferon alpha 2b-(G4S)n-thymosin alpha 1 fusion proteins in Pichia pastoris World J Gastroenterol 11 17 2005 2597 2602
83. Q. Yao, L.X. Doan, R. Zhang, U. Bharadwaj, M. Li, and C. Chen Thymosin alpha 1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes Immunol Lett 110 2 2007 110 120
84. W. Yao, Q. Zhu, Y. Yuan, M. Qiao, Y. Zhang, and Z. Zhai Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level J Gastroen Hepatol 22 11 2007 1866 1871
85. A. Yoshikawa, S. Isono, A. Sheback, and K. Isono Cloning and nucleotide sequencing of the genes rimI and rimJ which encode enzymes acetylating ribosomal proteins S18 and S5 of Escherichia coli K12 Mol Gen Genet 209 3 1987 481 488
86. J. You, L. Zhuang, H.Y. Cheng, S.M. Yan, Y.W. Qiao, and J.H. Huang A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in patients with chronic hepatitis B lacking HBeAg in China J Chin Med Assoc 68 2 2005 65 72
87. Y. Yu, J.H. Tian, K.H. Yang, and P. Zhang Evaluation of the efficacy of thymosin alpha 1 in the treatment of sepsis: a systemic review Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21 1 2009 21 24
88. P. Zhang, J. Chan, A.M. Dragoi, X. Gong, S. Ivanov, and Z.W. Li Activation of IKK by thymosin alpha 1 requires the TRAF6 signalling pathway EMBO Rep 6 6 2005 531 537
89. Y.Y. Zhang, E.Q. Chen, J. Yang, Y.R. Duan, and H. Tang Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis Virol J 6 2009 63
90. L. Zhou, Z.T. Lai, M.K. Lu, X.G. Gong, and Y. Xie Expression and hydroxylamine leavage of thymosin alpha 1 concatemer J Biomed Biotechnol 2008 2008 736060